FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3116131295> ?p ?o ?g. }

• W3116131295 endingPage "296" @default.
• W3116131295 startingPage "281" @default.
• W3116131295 abstract "Inhibition of phosphodiesterase 4 (PDE4) protects against neuronal apoptosis induced by cerebral ischemia. However, the exact mechanisms responsible for the protection of PDE4 inhibition have not been completely clarified. Roflumilast (Roflu) is an FDA-approved PDE4 inhibitor for the treatment of chronic obstructive pulmonary disease. The potential protective role of Roflu against ischemic stroke-associated neuronal injury remains unexplored. In this study, we investigated the effect and mechanism of Roflu against ischemic stroke using in vitro oxygen-glucose deprivation reperfusion (OGD/R) and in vivo rat middle cerebral artery occlusion (MCAO) models. We demonstrated that Roflu significantly reduced the apoptosis of HT-22 cells exposed to OGD/R, enhanced the nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf-2), and reduced oxidative stress. Treatment with Roflu increased the phosphorylation of protein kinase B (Akt) and glycogen synthase kinase 3β (GSK3β) but decreased the level of phosphorylated inositol requiring enzyme 1α (IRE1α). Interestingly, constitutively active GSK3β (S9A) mutation abolished the effects of Roflu on oxidative stress and IRE1α phosphorylation. Moreover, Roflu decreased the binding of IRE1α to tumor necrosis factor receptor-associated factor 2 (TRAF2) and attenuated the phosphorylation of c-Jun N-terminal kinase (JNK). We also found that PDE4B knockdown reduced the phosphorylation of both IRE1α and JNK, while overexpression of PDE4B antagonized the role of PDE4B knockdown on the activation of IRE1α and JNK. Besides, the inhibition of PDE4 by Roflu produced similar effects in primary cultured neurons. Finally, Roflu ameliorated MCAO-induced cerebral injury by decreasing infarct volume, restoring neurological score, and reducing the phosphorylation of IRE1α and JNK. Collectively, these data suggest that Roflu protects neurons from cerebral ischemia reperfusion-mediated injury via the activation of GSK3β/Nrf-2 signaling and suppression of the IRE1α/TRAF2/JNK pathway. Roflu has the potential as a protective drug for the treatment of cerebral ischemia." @default.
• W3116131295 created "2021-01-05" @default.
• W3116131295 creator A5002911339 @default.
• W3116131295 creator A5005486813 @default.
• W3116131295 creator A5015505166 @default.
• W3116131295 creator A5025751238 @default.
• W3116131295 creator A5049264813 @default.
• W3116131295 creator A5055620948 @default.
• W3116131295 creator A5064068343 @default.
• W3116131295 creator A5091584403 @default.
• W3116131295 date "2021-02-01" @default.
• W3116131295 modified "2023-10-11" @default.
• W3116131295 title "Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathway" @default.
• W3116131295 cites W2001399725 @default.
• W3116131295 cites W2063240911 @default.
• W3116131295 cites W2079445400 @default.
• W3116131295 cites W2112948259 @default.
• W3116131295 cites W2119774957 @default.
• W3116131295 cites W2125283476 @default.
• W3116131295 cites W2320637309 @default.
• W3116131295 cites W2600513789 @default.
• W3116131295 cites W2734950587 @default.
• W3116131295 cites W2744402516 @default.
• W3116131295 cites W2768222149 @default.
• W3116131295 cites W2770942713 @default.
• W3116131295 cites W2791340046 @default.
• W3116131295 cites W2792061750 @default.
• W3116131295 cites W2792404585 @default.
• W3116131295 cites W2809169118 @default.
• W3116131295 cites W2885038789 @default.
• W3116131295 cites W2898352757 @default.
• W3116131295 cites W2904223696 @default.
• W3116131295 cites W2915514667 @default.
• W3116131295 cites W2939598577 @default.
• W3116131295 cites W2948990161 @default.
• W3116131295 cites W2980292146 @default.
• W3116131295 cites W2982432905 @default.
• W3116131295 cites W2982449088 @default.
• W3116131295 cites W2982594794 @default.
• W3116131295 cites W2995050802 @default.
• W3116131295 cites W3002021571 @default.
• W3116131295 cites W3013741855 @default.
• W3116131295 cites W3013855701 @default.
• W3116131295 cites W3032963756 @default.
• W3116131295 cites W3043293892 @default.
• W3116131295 cites W3043509097 @default.
• W3116131295 cites W3043541583 @default.
• W3116131295 cites W3045296715 @default.
• W3116131295 cites W3078146326 @default.
• W3116131295 cites W3081641281 @default.
• W3116131295 cites W3174708708 @default.
• W3116131295 cites W4233435953 @default.
• W3116131295 cites W817231646 @default.
• W3116131295 doi "https://doi.org/10.1016/j.freeradbiomed.2020.12.018" @default.
• W3116131295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33359910" @default.
• W3116131295 hasPublicationYear "2021" @default.
• W3116131295 type Work @default.
• W3116131295 sameAs 3116131295 @default.
• W3116131295 citedByCount "39" @default.
• W3116131295 countsByYear W31161312952021 @default.
• W3116131295 countsByYear W31161312952022 @default.
• W3116131295 countsByYear W31161312952023 @default.
• W3116131295 crossrefType "journal-article" @default.
• W3116131295 hasAuthorship W3116131295A5002911339 @default.
• W3116131295 hasAuthorship W3116131295A5005486813 @default.
• W3116131295 hasAuthorship W3116131295A5015505166 @default.
• W3116131295 hasAuthorship W3116131295A5025751238 @default.
• W3116131295 hasAuthorship W3116131295A5049264813 @default.
• W3116131295 hasAuthorship W3116131295A5055620948 @default.
• W3116131295 hasAuthorship W3116131295A5064068343 @default.
• W3116131295 hasAuthorship W3116131295A5091584403 @default.
• W3116131295 hasConcept C104629339 @default.
• W3116131295 hasConcept C11960822 @default.
• W3116131295 hasConcept C126322002 @default.
• W3116131295 hasConcept C134018914 @default.
• W3116131295 hasConcept C182996813 @default.
• W3116131295 hasConcept C184235292 @default.
• W3116131295 hasConcept C185592680 @default.
• W3116131295 hasConcept C2776151105 @default.
• W3116131295 hasConcept C55493867 @default.
• W3116131295 hasConcept C71924100 @default.
• W3116131295 hasConcept C75217442 @default.
• W3116131295 hasConcept C98274493 @default.
• W3116131295 hasConceptScore W3116131295C104629339 @default.
• W3116131295 hasConceptScore W3116131295C11960822 @default.
• W3116131295 hasConceptScore W3116131295C126322002 @default.
• W3116131295 hasConceptScore W3116131295C134018914 @default.
• W3116131295 hasConceptScore W3116131295C182996813 @default.
• W3116131295 hasConceptScore W3116131295C184235292 @default.
• W3116131295 hasConceptScore W3116131295C185592680 @default.
• W3116131295 hasConceptScore W3116131295C2776151105 @default.
• W3116131295 hasConceptScore W3116131295C55493867 @default.
• W3116131295 hasConceptScore W3116131295C71924100 @default.
• W3116131295 hasConceptScore W3116131295C75217442 @default.
• W3116131295 hasConceptScore W3116131295C98274493 @default.
• W3116131295 hasFunder F4320321001 @default.
• W3116131295 hasFunder F4320335480 @default.
• W3116131295 hasFunder F4320335795 @default.

• next